Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.
Prakash AmbadyRongwei FuLaszlo SzidonyaDavid M PeereboomNancy D DoolittleEdward A NeuweltPublished in: Journal of neuro-oncology (2020)
We are evaluating the effectiveness of maintenance immunotherapy in PCNSL in a prospective multicenter randomized clinical trial.